- Feb 2, 2023
- 1 min
Ireland's HPRA: Guide to Clinical Trial Applications
- Feb 1, 2023
- 1 min
Health Canada Guidance: Conduct and Analysis of Comparative Bioavailability Studies
- Feb 1, 2023
- 1 min
ICH (USFDA) Guidance: Bioequivalence for Immediate-Release Solid Oral Dosage Forms
- Jan 31, 2023
- 1 min
USFDA Guidance: Design and Conduct of Externally Controlled Trials for Drug and Biological Products
- Jan 31, 2023
- 1 min
MHRA Guidance: Innovative Licensing and Access Pathway (updation)
- Jan 19, 2023
- 1 min
Malaysia MD Guidance: How to Submit an Application for Registration of a Refurbished Medical Device
- Jan 17, 2023
- 1 min
USFDA Guidance: Content & Format - Dosage and Administration Section of Labeling
- Jan 17, 2023
- 1 min
USFDA Guidance: Photobiomodulation (PBM) Devices & Premarket Notification [510(k)] Submissions
- Jan 16, 2023
- 2 min
EMA Guidance: Format & Validity Features of e-Certificates and How to Fll the Application Form
- Jan 8, 2023
- 1 min
Australia TGA: FAQ Importing & Supplying Medical Devices
- Jan 8, 2023
- 1 min
Philippines FDA: Draft Guidance Frontline Services of the FDA in the New Normal
- Jan 8, 2023
- 1 min
Irelands HPRA's: Guide to Fees for Human Products
- Jan 4, 2023
- 1 min
USFDA Guidance: Finalized REMS Format, Content and Technical Conformance Guide